朴荷生物科技(BYAH)

盘后1.560.02+1.30%19:51 EST

1.54-0.04-2.53%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- 美股异动丨Elong Power涨61.09%，为涨幅最大的中概股
  中金财经 · 02-05
  美股异动丨Elong Power涨61.09%，为涨幅最大的中概股
- 朴荷生物科技盘中异动早盘快速上涨6.53%
  市场透视 · 02-03
  朴荷生物科技盘中异动早盘快速上涨6.53%
- 朴荷生物科技公布后续公开发行定价，募资额达245万美元
  美股速递 · 01-27
  朴荷生物科技公布后续公开发行定价，募资额达245万美元
- 朴荷生物科技盘中异动下午盘大幅拉升6.11%
  市场透视 · 01-24
  朴荷生物科技盘中异动下午盘大幅拉升6.11%
- 朴荷生物科技盘中异动股价大跌7.05%
  市场透视 · 2025-12-29
  朴荷生物科技盘中异动股价大跌7.05%
- 朴荷生物科技盘中异动急速上涨5.26%
  市场透视 · 2025-12-24
  朴荷生物科技盘中异动急速上涨5.26%
- 朴荷生物科技盘中异动急速下挫8.94%
  市场透视 · 2025-12-17
  朴荷生物科技盘中异动急速下挫8.94%
公司概况
公司名称
朴荷生物科技
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://ir.parkha.cn
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
朴荷生物科技有限公司于2022年10月11日在开曼群岛注册成立。公司的业务主要包括开发自有护肤品牌、直接销售护肤产品和特许经营联盟推广。公司的“朴荷”品牌专注于为问题皮肤提供解决方案。该品牌成立于2016年，第一家门店于2017年开业。除了朴荷江苏直营的三家门店外，该公司在中国还有特许经营商。朴荷江苏还是专注于敏感肌肤护肤产品开发和改进的研发中心。Xinzhan负责营销和推广工作，是其特许经营业务的负责实体。朴荷上海是其特许经营人员的培训中心。
- 03-02
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 01-23
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2025-12-05
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2025-09-25
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2025-09-19
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2025-07-10
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-03
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-02-24
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-12-20
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-12-20
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-12-20
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-12-06
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-12-03
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2024-11-06
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-10-09
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence

分时
5日
日
周
月

数据加载中...

最高

1.59

今开

1.52

量比

0.86

最低

1.40

昨收

1.58

换手率

1.23%

热议股票

朴荷生物科技(BYAH)

公司概况

热议股票